Zeskind Benjamin J.'s Form 4 filing
Immuneering Corp (IMRX) · filed Sep 14, 2021
- Accession no.
- 0001415889-21-004382
- Filed
- Sep 14, 2021
- Trade date
- Sep 13, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $47.6K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Zeskind Benjamin J.CIK 0001870062 | Director, Officer (PRESIDENT AND CEO), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 13, 2021 | Class A Common Stock | PPurchaseAcquired | +2,083 | $22.87 | +$47,638.21 | 2,602,352 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.